Table 1.
Patient demographics
| Factor | MHs (n = 29) | Non-MHs (n = 63) |
|---|---|---|
| Gender (male) | 65.5% (19/29) | 66.7% (42/63) |
| Age, years | 37.6 (11.01) | 42.7 (16.12) |
| BMI, kg/m2 | 23.0 (4.15) | 22.4 (3.99) |
| Disease duration, years | 8.1 (7.50) | 6.6 (6.12) |
| Extent of disease, % (n/N) | ||
| Limited to left side colon | 67.7 (21/31) | 59.0 (36/61) |
| Extensive | 31.0 (9/29) | 41.3 (26/63) |
| Mayo scorea (0–12) | 8.3 (6; 11) | 7.8 (6; 11) |
| pMayo scoreb (0–9) | 6.0 (3; 8) | 5.4 (4; 8) |
| Severity of UC disease,c % (n/N) | 96.6 (28/29) | 98.4 (62/63) |
| CRP, mg/L | 5.5 (15.49) | 4.6 (10.84) |
| Corticosteroid dosage, mg/day | 2.7 (6.15) | 3.3 (6.05) |
| Extraintestinal manifestation,d % (n/N) | 75.9 (22/29) | 88.9 (56/63) |
| Calprotectin, mg/kg | 512.6 (387.53) | 439.5 (294.87) |
| Lactoferrin, µg/mL | 174.3 (255.10) | 184.0 (321.07) |
Patient characteristics of the patients showed mucosal healing at week 60 (MHs) and the patients did not show mucosal healing at week 60 (non-MHs).
a
Median (range)
b
Median (range)
c
moderate
d
absent.